Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression

Pei,Zhijun; Zeng,Jing; Gao,Yan; Li,Fuyan; Li,Wei; Zhou,Hong; Yang,Yi; Wu,Ruimin; Chen,Yijia; Liu,Jie

doi:10.3892/or.2016.4800

Oxymatrine inhibits the proliferation of CaSki cells via downregulating HPV16E7 expression

Authors:
- Zhijun Pei
- Jing Zeng
- Yan Gao
- Fuyan Li
- Wei Li
- Hong Zhou
- Yi Yang
- Ruimin Wu
- Yijia Chen
- Jie Liu
View Affiliations

Affiliations: Department of PET Center and Institute of Anesthesiology and Pain, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Infection Control, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Nuclear Medicine, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Province Key Laboratory of Molecular Imaging, Wuhan, Hubei 430022, P.R. China
Published online on: May 10, 2016 https://doi.org/10.3892/or.2016.4800
Pages: 291-298

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Treatment of recurrent and metastatic cervical cancer remains a challenge, especially in developing countries, which lack efficient screening programs. HPV16E7 has been reported to play an important role in the development of cervical cancer. In recent years, oxymatrine, which was traditionally used as anti-malarial agent, has been shown to inhibit tumor growth with low toxicity to normal cells. In the present study, we investigated the mechanisms underlying the antitumor effect of oxymatrine in cervical cancer. The CCK-8 assay was used to compare the proliferation of untreated and oxymatrine-treated cervical cancer CaSki cells. Flow cytometry was applied to observe the effect of oxymatrine on apoptosis and the cell cycle distribution of CaSki cells. We used qRT-PCR and western blot analysis to determine the mRNA level and protein level of HPV16E7. The HPV16E7 siRNA inhibition was also performed to confirm the effect of downregulating HPV16E7 on the proliferation in CaSki cells. Our results revealed that oxymatrine-treated cells showed time-dependent and dose-dependent inhibition of proliferation and a significant increase in apoptosis. Oxymatrine arrested CaSki cells in G0/G1 phase and S phase while decreased the cells in G2/M phase. The expression of HPV16E7 was significantly downregulated in oxymatrine-treated cells compared with control cells. Knock-down of HPV16E7 effectively inhibited the proliferation of CaSki cells. In conclusion, our data suggest that oxymatrine inhibits cervical cancer growth via downregulation of HPV16E7. Oxymatrine can be considered to be a potential preventive and therapeutic target for cervical cancer.

View Figures

View References

1	Aggarwal P: Cervical cancer: Can it be prevented? World J Clin Oncol. 5:775–780. 2014. View Article : Google Scholar : PubMed/NCBI
2	Wang KL: Human papillomavirus and vaccination in cervical cancer. Taiwan J Obstet Gynecol. 46:352–362. 2007. View Article : Google Scholar
3	Haedicke J and Iftner T: Human papillomaviruses and cancer. Radiother Oncol. 108:397–402. 2013. View Article : Google Scholar : PubMed/NCBI
4	Almajhdi FN, Senger T, Amer HM, Gissmann L and Öhlschläger P: Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: Optimization by different ways of sequence rearrangements (shuffling). PLoS One. 9:e1134612014. View Article : Google Scholar : PubMed/NCBI
5	Chen S, Liao C, Lai Y, Fan Y, Lu G, Wang H, Zhang X, Lin MC, Leng S and Kung HF: De-oncogenic HPV e6/e7 vaccine gets enhanced antigenicity and promotes tumoricidal synergy with cisplatin. Acta Biochim Biophys Sin (Shanghai). 46:6–14. 2014. View Article : Google Scholar
6	Duenas-Gonzalez A, Serrano-Olvera A, Cetina L and Coronel J: New molecular targets against cervical cancer. Int J Womens Health. 6:1023–1031. 2014. View Article : Google Scholar : PubMed/NCBI
7	Boulet GA, Horvath CA, Berghmans S and Bogers J: Human papillomavirus in cervical cancer screening: important role as biomarker. Cancer Epidemiol Biomarkers Prevy. 17:810–817. 2008. View Article : Google Scholar
8	Fei ZW, Qiu MK, Qi BQ, Dai YX, Wang SQ, Quan ZW, Liu YB and Ou JM: Oxymatrine suppresses proliferation and induces apoptosis of hemangioma cells through inhibition of HIF-1α signaling. Int J Immunopathol Pharmacol. 28:201–208. 2015. View Article : Google Scholar : PubMed/NCBI
9	Guo B, Zhang T, Su J, Wang K and Li X: Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells. Cancer Chemother Pharmacol. 75:353–363. 2015. View Article : Google Scholar
10	Li M, Su BS, Chang LH, Gao Q, Chen KL, An P, Huang C, Yang J and Li ZF: Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion. Anticancer Drugs. 25:161–173. 2014. View Article : Google Scholar
11	Wang B, Han Q and Zhu Y: Oxymatrine inhibited cell proliferation by inducing apoptosis in human lung cancer A549 cells. Biomed Mater Eng. 26(Suppl 1): S165–S172. 2015.PubMed/NCBI
12	Zhang Y, Sun S, Chen J, Ren P, Hu Y, Cao Z, Sun H and Ding Y: Oxymatrine induces mitochondria dependent apoptosis in human osteosarcoma MNNG/HOS cells through inhibition of PI3K/Akt pathway. Tumour Biol. 35:1619–1625. 2014. View Article : Google Scholar
13	Guzman JR, Koo JS, Goldsmith JR, Mühlbauer M, Narula A and Jobin C: Oxymatrine prevents NF-κB nuclear translocation and ameliorates acute intestinal inflammation. Sci Rep. 3:16292013. View Article : Google Scholar
14	Wang W, You RL, Qin WJ, Hai LN, Fang MJ, Huang GH, Kang RX, Li MH, Qiao YF, Li JW, et al: Anti-tumor activities of active ingredients in Compound Kushen Injection. Acta Pharmacol Sin. 36:676–679. 2015. View Article : Google Scholar : PubMed/NCBI
15	Ying XJ, Jin B, Chen XW, Xie J, XU HM and Dong P: Oxymatrine downregulates HPV16E7 expression and inhibits cell proliferation in laryngeal squamous cell carcinoma Hep-2 cells in vitro. BioMed Res Int. 2015:1503902015. View Article : Google Scholar : PubMed/NCBI
16	Sun M, Cao H, Sun L, Dong S, Bian Y, Han J, Zhang L, Ren S, Hu Y, Liu C, et al: Antitumor activities of kushen: Literature review. Evid Based Complement Alternat Med. 2012:3732192012. View Article : Google Scholar : PubMed/NCBI
17	Yamazaki M: The pharmacological studies on matrine and oxymatrine. Yakugaku Zasshi. 120:1025–1033. 2000.In Japanese. PubMed/NCBI
18	Jiang G, Liu X, Wang M, Chen H, Chen Z and Qiu T: Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2/HO-1 pathway. Acta Cir Bras. 30:422–429. 2015. View Article : Google Scholar : PubMed/NCBI
19	Liu L, Lu W, Ma Z and Li Z: Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway. Int J Mol Med. 29:815–822. 2012.PubMed/NCBI
20	Zhang TZ, Fu Q, Chen T and Ma SP: Anti-asthmatic effects of oxymatrine in a mouse model of allergic asthma through regulating CD40 signaling. Chin J Nat Med. 13:368–374. 2015.PubMed/NCBI
21	Zhao P, Zhou R, Li HN, Yao WX, Qiao HQ, Wang SJ, Niu Y, Sun T, Li YX and YU JQ: Oxymatrine attenuated hypoxic-ischemic brain damage in neonatal rats via improving antioxidant enzyme activities and inhibiting cell death. Neurochem Int. 89:17–27. 2015. View Article : Google Scholar : PubMed/NCBI
22	Liu Y, Bi T, Dai W, Wang G, Qian L, Gao Q and Shen G: Effects of oxymatrine on the proliferation and apoptosis of human hepatoma carcinoma cells. Technol Cancer Res Treat. May 24–2015.Epub ahead of print.
23	Cohen SM: Cell proliferation and carcinogenesis. Drug Metab Rev. 30:339–357. 1998. View Article : Google Scholar : PubMed/NCBI
24	Suda T: Physiological and pathological roles of apoptosis. Nihon Rinsho. 63(Suppl 4): 395–400. 2005.
25	Zörnig M, Hueber A, Baum W and Evan G: Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta. 1551:F1–F37. 2001.PubMed/NCBI
26	Cheng YM, Chou CY, Hsu YC, Chen MJ and Wing LY: The role of human papillomavirus type 16 E6/E7 oncoproteins in cervical epithelial-mesenchymal transition and carcinogenesis. Oncol Lett. 3:667–671. 2012.PubMed/NCBI
27	Hamada K, Shirakawa T, Gotoh A, Roth JA and Follen M: Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Gynecol Oncol. 103:820–830. 2006. View Article : Google Scholar : PubMed/NCBI
28	Zhou J, Peng C, Li B, Wang F, Zhou C, Hong D, Ye F, Cheng X, Lü W and Xie X: Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo. Gynecol Oncol. 124:296–302. 2012. View Article : Google Scholar
29	Wu XN and Wang GJ: Experimental studies of oxymatrine and its mechanisms of action in hepatitis B and C viral infections. Chin j Dig Dis. 5:12–16. 2004. View Article : Google Scholar : PubMed/NCBI
30	Yao N and Wang X: In vitro immunomodulatory activity of oxymatrine on Toll-like receptor 9 signal pathway in chronic hepatitis B. Am J Chin Med. 42:1399–1410. 2014. View Article : Google Scholar : PubMed/NCBI
31	Lin M, Yang LY, Li WY, Peng YP and Zheng JK: Inhibition of the replication of hepatitis B virus in vitro by oxymatrine. J Int Med Res. 37:1411–1419. 2009. View Article : Google Scholar : PubMed/NCBI